
Migraine, with Prof Tim Collins
BMJ Best Practice Podcast
00:00
Revamping Migraine Management
This chapter explores the advancements in migraine treatment through a new class of medications targeting calcitonin gene-related protein (CGRP). It highlights the FDA-approved erinumab, detailing its administration and minimal side effects compared to traditional therapies. The discussion also covers prescribing criteria and common pitfalls in headache management, emphasizing patient understanding and support.
Transcript
Play full episode